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The Hedgehog (Hh) signalling pathway plays important roles during embryonic development and in adult tissue
homeostasis, for example cartilage, where its deregulation can lead to osteoarthritis (OA). microRNAs (miRNAs)
are important regulators of gene expression, and have been implicated in the regulation of signalling pathways,
including Hh, thereby impacting upon development and disease. Our aim was to identify the function of miRNAs
whose expression is altered in OA cartilage. Here we identified an increase in miR-324-5p expression in OA
cartilage and hypothesised that, as in glioma, miR-324-5p would regulate Hh signalling. We determined that miR-
324-5p regulates osteogenesis in human mesenchymal stem cells (MSCs) and in mouse C3H10T1/2 cells.
Luciferase reporter assays demonstrated that miR-324-5p directly regulated established targets GLI1 and SMO in
human but not in mouse, suggesting species-dependent mechanism of Hh pathway regulation. Stable Isotope
Labelling with Amino acids in Cell culture (SILAC), mass spectrometry and whole genome transcriptome analysis
identified Glypican 1 (Gpc1) as a novel miR-324-5p target in mouse, which was confirmed by real-time RT-PCR,
immunoblotting and 3′UTR-luciferase reporters. Knockdown of Gpc1 reduced Hh pathway activity, and
phenocopied the effect of miR-324-5p on osteogenesis, indicating that miR-324-5p regulates Hh signalling in
mouse via direct targeting of Gpc1. Finally, we showed that human GPC1 is not a direct target of miR-324-5p.
Importantly, aswell as identifying novel regulation of IndianHedgehog (Ihh) signalling, this studydemonstrateshow
a miRNA can show conserved pathway regulation in two species but by distinct mechanisms and highlights
important differences between human diseases and mouse models.
© 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
The Hedgehog (Hh) signalling pathway is important
in embryonic development and adult tissue homeo-
stasis and is aberrantly activated in many human
diseases, including osteoarthritis (OA) [1]. The path-
way can be activated by one of threeHh ligands, Sonic
Hedgehog (Shh), Indian Hedgehog (Ihh) or DesertAuthor. Published by Elsevier B.V. T
g/licenses/by/4.0/).
: S. Woods, et al., miR-324-5p is up regul
chanisms in human a..., Matrix Biol (2018)Hedgehog (Dhh), all via their binding to the membrane
receptor Ptch. This binding results in loss of inhibition
on theHh signal transducer SMO, and accumulation of
active Hh transcription factor Gli1. Gli1 induces the
transcription of a number of Hh responsive genes
including itself, Ptch1 andHhip [2]. During skeletogen-
esis Ihh functions to regulate chondrocyte differentia-
tion and proliferation [3,4] by, for example, stimulatinghis is an open access article under the CC BY license
Matrix Biol. (2018) xx, xxx–xxx
ated in end-stage osteoarthritis and regulates Indian Hedgehog
, https://doi.org/10.1016/j.matbio.2018.08.009
Fig. 1. miR-324-5p expression is increased in OA and targets components of the Hh pathway in humans. (A) Human
articular cartilage samples obtained from femoral heads of patients with OA (n = 10) were compared with those from
patients undergoing hip replacement following fracture to the neck of femur (NOF; n = 10). RNA was purified, reverse
transcribed and assayed by qRT-PCR for miR-324-5p expression. Statistical differences were calculated using an
unpaired t-test with Welch's correction where **p b 0.01. (B and C) Schematic of miR-324-5p interaction with either wild-
type (wt) or mutant (mt) human GLI1 and SMO 3′UTR luciferase constructs. Seed sequence is underlined and in red.
SW1353 cells were transfected with either human GLI1 wild-type (w.t.), GLI1 mutant (mut), SMO w.t. or SMO mut 3′UTR
luciferase constructs (in pMIR-Report) with either miCon2 or miR-324-5p, data plotted as relative luciferase light units.
Data were combined from 5 independent experiments each n = 6. Statistical difference were calculated using a two-way
analysis of variance followed by Bonferroni post hoc test for multiple comparisons where *p b 0.05, ns = non-significant
(p N 0.05). Data are presented as standard error of the mean (SEM).
2 miR-324-5p regulates Ihh signallingparathyroid hormone related peptide (PTHrP) expres-
sion to induce chondrocyte proliferation and to prevent
hypertrophy during endochondral ossification [5].
Conversely, forced expression of Shh in chondrocytes
during development leads to joint fusion [6]. In
humans, mutations within IHH are known to cause
Brachydactyly type A1 [7] and Acrocapitofemoral
Dysplasia [8], two diseases involving skeletal abnor-
malities and short stature. Mice lacking Ihh also exhibit
a short-limb dwarfism phenotype [9].
OA is the most common musculoskeletal disease
and is epitomised by the loss of articular cartilage,
thickening of subchondral bone and the formation of
osteophytes [10–12]. The biological activity of the
cartilage cell, the chondrocyte, during OA involves re-
initiation of skeletal development pathways [13],
including Hh signalling. Hh signalling is thought to
contribute to the loss of cartilage by controlling
expression of cartilage degrading enzymes such as
matrix metalloproteinase (MMPs) [14], increasing
chondrocyte hypertrophy [14], the formation of osteo-
phytes, and thickening of subchondral bone. Mouse
models have shown alteration in Hh activity alone can
lead to early-onset-OA-like disease [1]. Additionally,
blockade of Hh signalling in both surgical and serum-
induced mice models of OA can be protective [1,15].Please cite this article as: S. Woods, et al., miR-324-5p is up regula
signalling by differing mechanisms in human a..., Matrix Biol (2018)Similarly, deletion of Ihh in mice can protect against
OA, consistent with Hh signalling contributing to OA
pathogenesis [1,16]. At the cellular level, knockdownof
IHH in humanchondrocytes decreasesbothCOL10A1
and MMP13 expression while the addition of exoge-
nous Ihh increases expression [14]. However, activa-
tion of Hh signalling also leads to increased collagen II
expression in rat meniscus [17] illustrating tight
regulation of the Hh pathway is required for cartilage
homeostasis.
MicroRNAs (miRNAs) are small (approximately
22 nt), single stranded, non-coding RNAs that modu-
late gene expression through base-specific interac-
tionswithin the target gene3′untranslated region (UTR)
causing translational inhibition and mRNA degradation
[18]. Numerous miRNAs influence the expression of
matrix components and matrix remodeling in various
diseases [19]. Through the generation of conditional
cartilage-specific Dicer null mice, the overall impor-
tance for miRNAs in skeletogenesis has been demon-
strated [20]. The mice, which lack virtually all cartilage
miRNAs, display severe developmental defects due to
a decrease in chondrocyte proliferation and a faster
onset of hypertrophy [20], processes in which Ihh is
known to play a role. Conditional removal of Dicer in
cells expressingShh in earlier limbdevelopment (with ated in end-stage osteoarthritis and regulates Indian Hedgehog
, https://doi.org/10.1016/j.matbio.2018.08.009
Fig. 2. miR-324-5p regulates osteogenesis in human cells and both hedgehog signalling and osteogenesis in mouse
C3H10T1/2 cells. (A and B) Human MSCs were transfected with either miCon or miR-324-5p (100 nM) for 2 days prior to
OsteoMax-inducedosteogenic differentiation in thepresenceor absenceof Ihh (2 μg/ml) andBMP2 (100 ng/ml). Representative
image from 1 donor following staining with Alizarin Red (n = 4/treatment) (A). Alizarin red was extracted using cetylpyridinium
chloride and absorbancemeasured at 620 nm. Data were combined from 3 donors, each n = 4 and presented as standard error
of themean (SEM). C3H10T1/2 cells were transfectedwithmiR-324-5p (100 nM) and stimulatedwith recombinant Ihh (2 μg/ml).
Gli1 expression was measured using real-time PCR (C) and immunoblotting (D). (E) C3H10T1/2 cells were transfected with
miCon2, miR-324-5p or exposed to transfection reagent alone and then stimulated with Ihh (2 μg/ml) and/or BMP2 (100 ng/ml)
for a period of 5 days. p-nitrophenylphosphate (pNPP) was measured to determine the level of alkaline phosphatase as an
indicator of osteoblastic differentiation. Data shown are combined data from 5 independent experiments each n = 3. Data are
presented as standard error of the mean (SEM). Throughout statistical differences were calculated using a one-way analysis of
variance followed by Bonferroni post hoc test where **p b 0.01, ***p b 0.001, ns = non-significant (p N 0.05).
3miR-324-5p regulates Ihh signallingShh-Cre recombinase) also causes alterations in limb
morphogenesis [21]. A number of miRNAs are
implicated in chondrocyte biology; in particular miR-
140 and miR-455 appear largely cartilage-specific
while others regulate pathways critical to chondrocyte
function [22]. miR-140 is highly expressed in cartilage
and mice which lack the miR-140 locus exhibit smaller
stature, skeletal development abnormalities and are
more susceptible to OA, illustrating the role of miRNAs
in maintaining chondrocyte function. Cartilage profilingPlease cite this article as: S. Woods, et al., miR-324-5p is up regul
signalling by differing mechanisms in human a..., Matrix Biol (2018)studies have identified a number of additional miRNAs
differentially regulated in OA [23,24].
Here we initially screened for differential microRNA
expression in normal (neck of femur fracture; NOF)
and OA cartilage, identifying miR-324-5p as upregu-
lated in the diseased tissuewhich hadpreviously been
associated with regulation of Hh signalling. Next we
used quantitative proteomic and transcriptomic micro-
RNA target identification to investigate the mecha-
nisms by which OA-associated miR-324-5p regulatesated in end-stage osteoarthritis and regulates Indian Hedgehog
, https://doi.org/10.1016/j.matbio.2018.08.009
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Fig. 3. miR-324-5p targets differ in human and mouse. (A and B) pMIR report plasmid containing either mouse Gli1 or
Smo 3′UTR downstream of luciferase was transfected into C3H10T1/2 cells with either miCon2 (miR-Con) or miR-324-5p.
Data were normalised to miCon2 and plotted as relative luciferase light units. Data were combined from 3 independent
experiments and presented as SEM. No differences were observed using a Student's t-test (p N 0.05). (C and D) miR-324-
5p target identification by 4 commonly used target prediction software for mouse and human. (E) Crossover of miR-324-5p
target prediction between mouse and human.
4 miR-324-5p regulates Ihh signallingthe hedgehog signalling pathway in humans and
mice.Results
miR-324-5p is increased in end-stageosteoarthritic
cartilage and targets components of the Hh
pathway in human cells
To identify miRNAs differentially expressed in
OA, a TaqMan® low density array of 365 miRNAs
was performed on cartilage RNA. Samples were
obtained from total hip replacements for either OA
or fracture to the neck of femur (NOF). Data were
normalised to the mean expression value of the
miRNAs profiled, using a previously publishedPlease cite this article as: S. Woods, et al., miR-324-5p is up regula
signalling by differing mechanisms in human a..., Matrix Biol (2018)method [25]. A number of miRNAs were differen-
tially expressed [26]. One miRNA of particular
interest was miR-324-5p, whose expression was
only detectable in the majority of OA, but not the
control (NOF), cartilage (Fig. 1A).
Ferretti et al. [27] previously reported that miR-324-
5p regulated Hh signalling in human medulloblastoma
via direct targeting of the GLI1 and SMO 3′UTR. To
confirm this in chondrocytes, we similarly cloned the
human 3′UTRs of GLI1 and SMO, placing the
expression of luciferase under their control. In agree-
ment, co-transfection of miR-324-5p reduced the
luciferase activity of both constructs (Fig. 1B and C).
Furthermore, mutation of the putative miR-324-5p
complementary seed sites within both the GLI1 and
SMO 3′UTRs prevented miR-324-5p from exerting its
repressive effects on the constructs (Fig. 1B and C),
confirming miR-324-5p acts directly on the humanted in end-stage osteoarthritis and regulates Indian Hedgehog
, https://doi.org/10.1016/j.matbio.2018.08.009
Fig. 4. miR-324-5p target identification in Ihh treated mouse C3H10T1/2. (A) Enrichment of genes containing 3′UTR miR-
324-5p binding sites within genes whose protein decreased (blog2 −0.2) following miR-324-5p transfection. (B) Cumulative
fraction plot showing enrichment of conserved and non-conserved miR-324-5p binding site containing genes whose protein
expression decreased followingmiR-324-5p over expression. (C) Enrichment of genes containing 3′UTRmiR-324-5p binding
siteswithin geneswhoseRNAdecreased (blog2−0.2) followingmiR-324-5p transfection. (D)Cumulative fraction plot showing
enrichment of conserved and non-conserved miR-324-5p binding site containing genes whose transcript expression
decreased following miR-324-5p over expression. (E) Proteomic and transcriptomic expression for 176 genes identified at a
protein andmRNA level and also contain amiR-324-5p seedbinding site, 18 ofwhich decreased at anmRNAandprotein level
(highlighted in red). (F) Bar chart showing log2 fold change in protein andRNAexpression for the 18 potential targets following
miR-324-5p transfection. Enrichment significance for miR-324-5p binding site containing genes was calculated using Chi-
squared test, where ***p b 0.001.
5miR-324-5p regulates Ihh signallingSMO and GLI1 3′UTR, as proposed in medulloblasto-
ma [27]. Interestingly, the expression of SMO and GLI
are both also increased in OA cartilage (Supplemen-
tary Fig. 1), suggesting miR-324-5p is part of a larger
regulatory network of Hh signalling.Please cite this article as: S. Woods, et al., miR-324-5p is up regul
signalling by differing mechanisms in human a..., Matrix Biol (2018)miR-324-5p regulates osteogenesis in human
bone marrow derived mesenchymal stem cells
The Hh signalling pathway is known to be involved
in bone formation [28]. We therefore hypothesisedated in end-stage osteoarthritis and regulates Indian Hedgehog
, https://doi.org/10.1016/j.matbio.2018.08.009
6 miR-324-5p regulates Ihh signallingmiR-324-5p was also involved in this process.
Overexpression of miR-324-5p in human bone
marrow derived mesenchymal stem cells (MSCs)
reduced the level of Alizarin Red staining following
osteogenic induction, both in the presence and
absence of additional BMP2 and Ihh, indicating
miR-324-5p can regulate osteogenesis in human
cells (Fig. 2A and B).miR-324-5p regulates Hedgehog signalling and
osteogenesis in mouse C3H10T1/2
Since the miR-324-5p sequence is perfectly
conserved between humans and mice, we also
used the mouse pluripotent cell-line C3H10T1/2 to
test the functional activity of miRNA, since under the
correct stimuli these cells have the ability to undergo
osteogenic differentiation [29]. Gli1, a Hh signalling
transcription factor whose expression also increases
following Hh stimulation as part of a positive
feedback loop, was used as a readout of Hh
signalling activity. Overexpression of miR-324-5p
inhibited Ihh-induced Gli1 mRNA and protein ex-
pression (Fig. 2C and D), demonstrating that miR-
324-5p can regulate Hh signalling in mouse
C3H10T1/2 cells. BMP2 and Ihh can induce high
levels of alkaline phosphatase in C3H10T1/2,
indicative of osteogenesis [29] (Fig. 2E). Consistent
with the effect on Hh signalling, overexpression of
miR-324-5p reduced the level of Ihh and BMP2-
induced alkaline phosphatase (Fig. 2E).
miR-324-5p targets differ in human and mouse
To test if miR-324-5p regulated IHH signalling via
direct targeting of Gli1 and Smo in mouse we
generated mouse specific 3′UTR luciferase con-
structs to recapitulate the effect miR-324-5p has in
the human system. However, miR-324-5p did not
repress activity from either reporter (Fig. 3A and B),
despite the clear regulation of Hh signalling in the
mouse C3H10T1/2 cell line (Fig. 2C and D). Exam-
ination of the mRNA sequences revealed neither
murine Gli1 nor Smo 3′UTR contained any highly
seed-complementary (‘8mer’, ‘7mer-m8’ or ‘7mer-1a’)
binding sites for miR-324-5p. Together, these data
would suggest that miR-324-5p regulates Hh signal-
ling in human and mouse via differing mechanisms.
To elucidate alternative potential targets of miR-324-
5p in mouse that may regulate Hh signalling we
combined data from 4 commonly used prediction
algorithms; PicTar [30], TargetScan [31], DIANA-
microT [32] and miRanda [33] giving a total of 3061
different predicted targets, however there were only
12 targets in common between databases (Fig. 3C),
none of which had a known role in Hh signalling. A
similar number of human targets were also predicted
(Fig. 3D), with the majority of predicted targets beingPlease cite this article as: S. Woods, et al., miR-324-5p is up regula
signalling by differing mechanisms in human a..., Matrix Biol (2018)species specific (Fig. 3E). Given the large number and
range of predicted targets and lack of consistency
between prediction algorithms, we sought to identify
murine miR-324-5p targets involved in Hh signalling
experimentally.
Identification of direct miR-324-5p targets
We used stable isotope labelling with amino acids in
cell culture (SILAC) quantitative proteomics [34] to
identify target proteins of miR-324-5p in Ihh-stimulated
C3H10T1/2 cells. Following miR-324-5p overexpres-
sion, 255 proteins were decreased and 227 were
increased, 36 and 18 of which contain a predictedmiR-
324-5p target site respectively. This finding indicatesan
enrichment of miR-324-5p target site containing genes
in the proteins whose expression decreased following
miR-324-5p overexpression (Fig. 4A). This enrichment
wasstrongest for conserved targets, at log2−0.2 cut-off
(Fig. 4B), suggesting SILAC proteomics as a valid tool
to identify direct miR-324-5p targets.
Overexpression of miRNAs followed by tran-
scriptome profiling (RNA hybridisation microarray)
has also previously been used to screen for miRNA
targets [35]. Therefore, using similar parameters to our
SILAC screen, we overexpressed miR-324-5p and
stimulated C3H10T1/2 cells with Ihh. Following miR-
324-5p overexpression, 2975 and 2958 transcripts
were decreased and increased respectively, 409 and
222 of which contain a predicted miR-324-5p target
respectively. As previously, this represents an enrich-
ment of miR-324-5p target site containing genes in
thosewhose transcript expression decreased following
miR-324-5p mimic transfection (Fig. 4C). Once more,
there was a greater enrichment of conserved targets
over non-conserved targets (Fig. 4D). Pathway analy-
sis of the 200 most decreased transcripts following
miR-324-5p over-expression identifies an enrichment
of genes associatedwith the extracellularmatrix (ECM)
and developmental proteins (Supplementary Table 1),
suggesting an important role for miR-324-5p in such
processes. Interestingly, enrichment in Wnt signalling
pathway associated genes was also detected (Sup-
plementary Table 1) illustrating the close relationship
between Hh and Wnt signalling.
In total, 2086 genes were identified in both the
transcriptome and proteomic screens, 176 of which
contain a knownmiR-324-5p binding site in their 3′UTR
(Fig. 4E). For 18 of these genes, expression decreased
at both transcript and protein level by greater then log2
0.2 (Fig. 4F) and thus could be considered as potential
miR-324-5p targets. None of these 18 potential targets
are within the Hh KEGG pathway [36]. The most
repressed potential target identified was Glypican 1
(Gpc1). Although Gpc1 is not found within the Hh
KEGG pathway, family members of Gpc1 have been
shown to play a role in Hh signalling [37–39]. We
therefore hypothesised that Gpc1 could be a target of
miR-324-5p in mouse, regulating Hh signalling.ted in end-stage osteoarthritis and regulates Indian Hedgehog
, https://doi.org/10.1016/j.matbio.2018.08.009
Fig. 5. miR-324-5p targets Gpc1 to regulate Hh signalling in mouse C3H10T1/2. (A) Real time RT-PCR analysis of
Gpc1 mRNA following siGpc1 or miR-324-5p transfection. Data are presented as SEM. (B) Western blot analysis of Gpc1
protein following siGpc1 and miR-324-5p transfection. (C) Schematic showing potential interaction of miR-324-5p with 3
different binding sites in mouse Gpc1 3′UTR. (D) pMIR reporter plasmid containing either wild type, mutant site 1, mutant
site 2 or mutant site 3 mouse Gpc1 3′UTR down stream of luciferase was transfected into C3H10T1/2 cells with either
miCon2 or miR-324-5p. Data were normalised to miCon2 and plotted as relative luciferase light units. Data were combined
from 5 independent experiments, each n ≥ 6. (E) siGli1 and siGpc1 effect on basal and Ihh stimulated Gli1 mRNA
expression. C3H10T1/2 cells were transfected with non-targeting siCon or siRNA against Gpc1 or Gli1 for 24 h. Cells were
then serum starved for 24 h and either left unstimulated or stimulated with Ihh (2 μg/ml) for 24 h. Data were combined from
4 independent experiments, each n = 4. (F) siGli1 and siGpc1 effect on basal and Ihh stimulated Gli1 protein expression,
cells treated as in D. Representative blot of 3 independent experiments. Throughout statistical differences were
calculated using a one-way analysis of variance followed by Bonferroni post hoc test where **p b 0.01, ***p b 0.001, ns =
non-significant (p N 0.05).
7miR-324-5p regulates Ihh signallingGpc1 is a direct miR-324-5p target and regulator
of Hh signalling in mouse
Targeting of Gpc1mRNAand protein bymiR-324-5p
was confirmed in mouse C3H10T1/2 cells (Fig. 5A and
B). Next, we validated Gpc1 as being a direct target of
miR-324-5p using a mouse Gpc1 3′UTR-luciferasePlease cite this article as: S. Woods, et al., miR-324-5p is up regul
signalling by differing mechanisms in human a..., Matrix Biol (2018)construct (Fig. 5C). Further analysis of themouseGpc1
3′UTR identified 3 potential miR-324-5p seed matches
(all ‘7mer-m8’). Site-directedmutagenesis of each seed
matched sequence indicated only themost distal 3′ site
(here named as site 3) is functional (Fig. 5D).
To test if Gpc1 is important for Hh signalling,
C3H10T1/2 cells were depleted of Gpc1 using siRNAated in end-stage osteoarthritis and regulates Indian Hedgehog
, https://doi.org/10.1016/j.matbio.2018.08.009
Fig. 6. miR-324-5p regulates Hh signalling by different mechanisms in human and mouse. (A) pMIR reporter plasmid
containing human GPC1 3′UTR downstream of luciferase was transfected into SW1353 cells with either miCon2 or miR-
324-5p. Data shown were normalised to miCon2 and plotted as relative luciferase light units. No difference was observed
between groups using Student's t-test (p = 0.92). Data are presented as SEM. (B and C) Schematic showing proposed
miR-324-5p regulation of Hh signalling in human and mouse.
8 miR-324-5p regulates Ihh signallingtransfection and stimulated with Ihh, again Gli1
transcript and protein was used as a readout for Hh
pathway activation. As with miR-324-5p transfection
(Fig. 2C and D), siGpc1 transfected cells showed
reduced levels of Gli1 following stimulation (Fig. 5E and
5F), indicating Gpc1 is required for Ihh signalling in
murine cells.
miR-324-5p does not target human GPC1
Analysis of the human GPC1 3′UTR identified one
centrally located putative miR-324-5p seed binding
site, though this was a relatively poor ‘7mer’. A
human GPC1 3′UTR luciferase construct was then
created, expression was surprisingly unaffected by
miR-324-5p (Fig. 6A), suggesting that human GPC1
is not a direct target of miR-324-5p.Discussion
HereweshowmiR-324-5p regulationofHhsignalling
is conserved in humans and mice, yet the regulatory
mechanism is not. In order to regulate Hh signalling in
humans, miR-324-5p targets SMO and GLI1, but not
GPC1, whereas in mice, miR-324-5p targets Gpc1, but
not Smo or Gli1 (Fig. 6B and C).
Initially to identify miRNAs differentially expressed in
OA, we screened end-stage OA articular cartilage and
used healthy articular cartilage from Neck of femur
fracture (NOF) patients as controls. These sample
types have been previously used to identify differences
between OA and healthy cartilage [40]; including
miRNA expression differences [26]. This study is the
first to show miR-324-5p is differentially expressed in
OA cartilage; in fact miR-324-5p was only detected in
OA cartilage. Although lowly expressed, miR-324-5p
has previously been identified in cartilage [41,42].
Crowe et al. found 0.003% of all miRNA RNA-seq
reads mapped to miR324-5p, which represented the
172nd (out of 990 identified) most abundant miRNA inPlease cite this article as: S. Woods, et al., miR-324-5p is up regula
signalling by differing mechanisms in human a..., Matrix Biol (2018)OA cartilage [41]. Hasseb et al., also identified miR-
324-5p in isolated primary chondrocytes, however was
only the 319th (out of 437 identified) most abundant
miRNA and represented only 0.0003% of all miRNA
reads [42].
Given the role of Hh signalling in OA [1], the data
herein expands knowledge on regulation of Hh
signalling during OA. Hh signalling activity is increased
during human OA and in the destabilization of the
medial meniscus (DMM) mouse OA model [1],
indicative of developmental pathway reinitiation.
Hedgehog inhibition protects cartilage against OA
(SMO inhibition reduces hypertrophy and osteophyte
formation) in mice [15]. Interestingly, the expression of
miR-324-5p (here apotentHh inhibitor), SMOandGLI1
(human targets) and GPC1 (mouse target) are all
increased in our human OA dataset, suggesting miR-
324-5p plays an important part of a complex hedgehog
regulatory network. We hypothesise increased miR-
324-5p is part of a failed attempt by the chondrocytes to
reduce Hh signalling, however, future studies to
modulate the levels of miR-324-5p in models of OA,
are needed to determine if it has a positive or negative
impact on OA severity.
MiRNAs often have many targets, with both miRNA
and target requiring temporo-spatial co-expression for
effective regulation. Therefore to identify miR-324-5p
targets involved in Hh regulation, C3H10T1/2 were
stimulated with Ihh, ensuring potential target mRNA
important for Hh signalling regulation were expressed.
Since the majority, of miRNA targets are decreased at
an mRNA and protein level [43], we combined both
transcriptome microarray and quantitative proteomics
(SILAC) data to identify Gpc1 as a potential miR-324-
5p target. The mouse Gpc1 3′UTR contained three
potential miR-324-5p binding sites, however, only the
most distal site was functional, supporting the obser-
vation that sites closer to the ends of the 3′UTRs are
more effective targets [44,45].
Members of the glypican family have been reported
to regulate Hh signalling. For example, Gpc3 in miceted in end-stage osteoarthritis and regulates Indian Hedgehog
, https://doi.org/10.1016/j.matbio.2018.08.009
9miR-324-5p regulates Ihh signallingand Dally-like protein in Drosophila are described as
being involved in Hh signalling [37,46]. Data has
linked GPC1 with Shh in Biliary atresia [47] and
importantly identified GPC1 as a Shh receptor in
commissural neurons [48]. Glypicans are a class of
Glycosylphosphatidylinositol (GPI) anchored mem-
brane heparin sulphate proteoglycan (HSPG) con-
sisting of a core protein with chains of heparan
sulphate (HS) glycos-amino-glycan (GAG) chains
[19,49]. HSPGs, such as glypicans, can interact with
morphogens to produce and regulate morphogen
gradients, for review see [50]. Thus it is suggested
glypicans function in Hh signalling by either seques-
tering or presenting Hh ligands via their HS chains to
Hh receptor Ptch. An interesting observation in our
SILAC proteomics experiment was that transfection
of miR-324-5p caused a reduction in the amount of
added Ihh protein detected within the cell lysate
(Supplementary Fig. 2). This indicates that over-
expression of miR-324-5p and subsequent reduc-
tion in Gpc1 reduce the capability of the cell to
uptake, present or retain Ihh ligand as suggested
previously for Shh [51]. Glypican family members
are known to regulate Hh signalling within the
growth plate [52], potentially suggesting a role for
miR-324-5p during rodent limb development as well
as during OA.
HS is a well-established regulator of cartilage
development and maintenance [49,53]. Consistent
with this, before directly confirming a role for Gpc1 in
Hh signalling, we cultured cells in sodium chlorate,
which inhibits HS formation, and showed this
reduced Ihh-induced Gli1 expression, confirming
an overall role for HS in Ihh signalling (Supplemen-
tary Fig. 3). Interestingly, transient overexpression
of Gpc1 also inhibited Hh signalling (Supplementary
Fig. 4) indicating a Goldilocks zone. Indeed,
glypicans have previously also been shown to
interact with multiple morphogens to both promote
and inhibit cell signalling, for example, Gpc3 can
directly interact with Shh to cause endocytosis and
lysosomal degradation leading to Hh signalling
inhibition [37]. Gpc3 can also interact with Wnts to
promote the Wnt signalling pathway [37,54]. When
considered together with our pathway analysis, data
may suggest miR-324-5p regulates Wnt signalling
through a mechanism also involving Gpc1.
Genotype-phenotype correlations show Glypican 1
can be a cause of skeletal deformities in rodents and is
highly expressed in developing and mature osteo-
blasts [55]. In humans the Glypican 1 gene has
previously been identified as a possible candidate for
causing Brachydactyly Type E, an inherited condition
causing skeletal deformities [56]. miR-324-5p and
Gpc1 are also highly expressed in the nervous system
[56]. In humans, patients with a loss of the genomic
locus containing GPC1 (chromosome 2q) display
skeletal deformities and also mental retardation [56].
In mice Gpc1 deletion alters brain size and leads toPlease cite this article as: S. Woods, et al., miR-324-5p is up regul
signalling by differing mechanisms in human a..., Matrix Biol (2018)increased risk of cancer, however animals show no
skeletal phenotype, as is frequently reported for
deleted matrix-associated genes; e.g. Matrilin-3, [57].
Gpc1 is unlikely to be the sole mechanism by which
miR-324-5p exerts any effects on the nervous system,
and in fact we found that miR-324-5p can also inhibit
App expression (Fig. 4F); a gene whose protein
contributes to brain pathogenesis, such as in Alzhei-
mer's disease.
Froman evolutionary perspective themiR-324 stem
loop is predicted to have arisen in the genome around
100 million years ago with the appearance of placen-
tal animals [58]. Given this age, it is interesting that
miR-324-5p regulates Hh signalling in humans and
mouse by potentially differing mechanisms, targeting
human GLI1 and SMO and mouse Gpc1 to inhibit Hh
signalling. We confirmed this differential regulation
using 3′UTR luciferase assays which remain the
standard technique for validating direct targets of
miRNAs.We also found no evidence that miR-324-5p
could regulate human GPC1 transcript levels. Our
data are consistent with the notation that miRNA:
target interactions are not fixed during evolution [59],
although the overall impact of miR-324-5p is to
regulate Hh in both species. As glypicans have been
shown to regulate a number of other morphogens, it is
possible miR-324-5p inhibition of Gpc1 in mice may
serve as a function to regulate morphogen signalling
on a more general level, rather than regulate the core
Hh signalling genes as miR-324-5p does in human.
Future studies should address the role miR-324-5p
plays in cartilage development and maintenance in
the context of hedgehog signalling for both mice and
humans.
Our data illustrates miR-324-5p targets Gpc1 to
regulate Ihh signalling and likely other morphogens
in mice, whereas in humans miR-324-5p is a more
direct regulator of Hh signalling. This study highlights
the importance of using human cells to study human
development and disease, particularly in the context
of miRNAs and hedgehog signalling. In conclusion
miR-324-5p expression is increased in OA cartilage
compared to healthy cartilage and regulates the Hh
signalling pathway in human and mouse, but does
so via differing mechanisms.Materials and methods
Differential expression of miRNAs in OA vs.
normal cartilage
A differential expression screen of miRNAs in OA
cartilage obtained from patients undergoing joint
replacement and healthy cartilage obtained from
patients following fracture of the neck of femur (NOF),
was performed and analysed as previously described
[26].ated in end-stage osteoarthritis and regulates Indian Hedgehog
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SW1353 were cultured in Dulbecco's Modified
Eagle's medium (Sigma), supplemented with 10%
foetal bovine serum (FBS, Sigma-Aldrich), 2 mM L-
glutamine, 1% non-essential amino acid solution,
100 IU/ml penicillin and 100 μg/ml streptomycin.
Human MSC were cultured in mesenchymal stem
cell growth medium (Lonza Biosciences) supplement-
ed with 5 ng/ml fibroblast growth factor-2 (R&D
Systems, Abingdon, U.K.). For all experiments involv-
ing C3H10T1/2mouse pluripotent mesenchymal cells,
with the exception of SILAC experiments, cells were
cultured inMinimumEssential Medium, supplemented
as described for SW1353 cells. All cells were cultured
in vented T75 cm2 flasks at 37 °C and 5% (v/v) CO2.
Plasmid construction
Potential target 3′UTRs were amplified from
genomic DNA using PCR primers (Supplementary
Table 2) for In-Fusion® cloning (Clontech) or double-
restriction enzyme digestion (SpeI/HindIII) to enable
cloning into the pMIR-Reporter vector (Ambion).
Mutation of the miRNA seed binding sites was
performed using QuickChange II (Agilent). Mouse
Gpc1 overexpression plasmid was generated by
infusion cloning of Gpc1 cDNA clone (Source
Bioscience) into N-terminal HaloTag® expression
construct (Promega).
Plasmid, siRNA and miRNA transfections
SW1353 chondrosarcoma cells (for human 3′UTRs)
or mouse C3H10T1/2 cells (for mouse 3′UTRs, siRNA
and miRNA) were seeded to reach ~50% confluence
after 24 h, representing 1.8 × 104 cells/cm2 for
SW1353, 1.2 × 10 4 cells/cm 2 for MSC and
9 × 103 cells/cm2 for C3H10T1/2. miRNA and
siRNA (50–100 nM) were transfected using Dharma-
fect transfection reagent 1 (DF1, Dharmacon). Ex-
pression and reporter plasmids (500 ng/ml) were
transfected using FugeneHD. For miRNA and reporter
plasmid co-transfection incubated lipid complexes
were added to cells simultaneously, essentially as
previously described [60]. Transfection reagents alone
were used as controls. After the 24 h of transfection,
cells were lysed and luciferase levels determined
(Promega) using a Microlumat Plus Luminometer, or
were cultured further for stimulation and differentiation
experiments.
Human MSC osteogenesis and Alizarin Red
staining
Human MSCs were cultured and transfected with
either miCon or miR-324-5p in 96 well plates as
described above. After 48 h media was replaced
with OsteoMax medium (Merck Millipore) in thePlease cite this article as: S. Woods, et al., miR-324-5p is up regula
signalling by differing mechanisms in human a..., Matrix Biol (2018)presence or absence of Recombinant Indian Hedge-
hog (Ihh) (2 μg/ml; R&D systems) and BMP2
(100 ng/ml; R&D systems). Fresh OsteoMax medi-
um was added after 4 days. After 7 days cells were
fixed in 10% formalin and mineralisation assessed
by incubation with Alizarin Red solution (Sigma)
(40 mM, pH 4.2) for 30 min. For quantification the
staining was extracted with 10% (w/v) cetylpyridi-
nium (Sigma) solubilised in 10 mM sodium phos-
phate buffer (pH 7) and the absorbance measured at
620 nM.
Cell stimulation
C3H10T1/2 cells (with or without transfection) of
80–90% confluence were serum-starved for 16 h
and stimulated with either Ihh or BMP-2 for the time
and concentration indicated in each figure.
RNA isolation, reverse transcription and real-
time PCR
Total RNA was extracted using Cells-to-cDNA II Kit
(Ambion, Huntington, UK). Complementary DNA
(cDNA) was synthesised from total RNA using MMLV
reverse transcriptaseand randomhexamers according
to the manufacturer's instructions (Life Technologies).
mRNA levels were determined using TaqMan® real
time PCR. Assay primers and probes are listed or
numbered as in the universal probe library (Roche) in
Supplementary Table 2. For miRNAs, cDNA was
synthesised from totalRNAusingTaqMan®MicroRNA
ReverseTranscription (Life Technologies) according to
the manufacturer's instructions. Real-time PCR was
carried out using Life Technologies miRNAs assays
according to the manufacturer's instructions.
Immunoblotting
Cellswere lysedusing icecold lysis buffer containing:
50 mM Tris-HCl, 1.2 M glycerol, 1 mM EGTA, 1 mM
EDTA, 1 mM Na3VO4, 10 mM 2-glycerophosphate,
50 mM NaF, 5 mM sodium pyrophosphate, 1% (v/v)
Triton X-100, 1 μM microcystin-LR and 0.1% (v/v) 2-
mercaptoethanol. Particulates were removed by cen-
trifugation at 13,000g for 5 min, supernatants were
frozen at −80 °C until needed. To determine protein
concentration, Bradford reagent (Biorad) was added to
the lysate, absorbance measured at 595 nm with a
plate reader (TECAN) and protein concentrations
equalised. Proteins (5 μg per sample) were separated
by SDS-PAGE electrophoresis, transferred to nitrocel-
lulose membrane and probed with antibodies against
Gli1 (V812, Cell Signalling, 1/1000), Gpc1 (16700-1-
AP, Protein Tech Group, 1/1000), GAPDH (Chemico
International, 1/1000) or β-tubulin (1/1000). Expression
was monitored by chemiluminescence (GE
Healthcare) usingHRP conjugated secondary antibod-
ies (1/2000).ted in end-stage osteoarthritis and regulates Indian Hedgehog
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C3H10T1/2 cells were cultured and transfected as
described above in 24 well plates. After 48 h the
cells were stimulated as indicated (Fig. 2C) in serum
containing medium for 5 days. Culture medium was
refreshed at day 3, after which cells were assessed
for alkaline phosphatase activity. Briefly, cells were
washed with PBS, fixed with 4% (w/v) formaldehyde,
washed with HEPES and alkaline phosphatase
substrate (p-nitrophenylphosphate, Sigma) added.
Active alkaline phosphatase (produced p-
nitrophenol) was measured at 405 nm, using a
TECAN plate reader and Xflor 4 software.
SILAC and mass spectrometry
C3H10T1/2 cells were cultured for more than five
population doublings (7 days of culture), in DMEM
containing either isotopically labelled 13C L-Lysine-
2HCl and 13C 15N L-Arginine-HCl (heavy), or normal
Lysine and Arginine (light). Both heavy and light
media contained dialysed FBS (all SILAC media,
amino acids and FBS were supplied by Thermo
Scientific). After 7 days of culture, the isotopic
incorporation of the heavy amino acids was
assessed. More than 99% of the peptides assessed
by mass spectrometry contained heavy Arginine and
Lysine (data not shown). Both heavy and light cells
were seeded in 6 cm dishes to reach around 50%
confluence after 24 h. Cells were then transfected
using DF1 with 100 nM of either miCon2 (non-
targeting miRNA mimic) or miR-324-5p mimic in the
light and heavy cells, respectively. After 24 h of
transfection, cells were serum-starved for a further
16 h and then stimulated with 2 μg/μl recombinant
Ihh for 48 h. Cells were then lysed using 150 μl of
lysis buffer, as described for immunoblotting. The
Heavy and Light lysates were then mixed at a ratio of
1:1. Protein was boiled and separated using SDS-
PAGE with nanopure H2O used in all gels and
buffers. Gel preparation, protein digestion, mass
spectrometry and initial processing of data was
performed by NEPAF, Newcastle University. Gels
were cut into 12 segments, each digested with
trypsin and analysed by mass spectrometry. Data
were normalised and analysed using MaxQuant
software as described previously [61].
Total RNA isolation and microarray
C3H10T1/2 cells were cultured as described and
seeded into 6 well plates at a density of 8.2 × 104 cells
perwell for 24 h.Cellswere then transfected usingDF1
and 100 nM of either miCon2 or miR-324-5p for 24 h.
Cells were then serum starved for 16 h before being
stimulated for a further 48 h as described. Cells were
then lysed and RNA extracted using the Qiagen
RNeasy mini kit according to the manufacturer'sPlease cite this article as: S. Woods, et al., miR-324-5p is up regul
signalling by differing mechanisms in human a..., Matrix Biol (2018)protocol. Microarray analysis used the Illumina
mouse ref8 v3 bead array and was performed by The
Genome Centre, Queen Mary, University of London.
Raw expression data were analysed using Agilent
GeneSpring GX 11 (Agilent Technologies, Santa
Clara, CA, U.S.A.). Raw data were normalised with a
quantile algorithm and the baseline was transformed to
the median of all samples prior to further analysis.
Seed enrichment analysis
Enrichment analysis was performed by calculating
the fraction of genes containing miR-324-5p binding
site within the 3′UTR, for decreased (FC b log2
−0.2), increased (FC N log2 0.2) and unaltered
transcripts and proteins. The list of genes whose 3′
UTR contained a miR-324-5p binding site was
obtained from TargetScan.
Cumulative fraction plots were generated by
plotting FC gene expression on the x axis against
the fraction of all genes whose 3′UTR contain (or
does not contain for control) a miR-324-5p binding
site on the y axis for all genes whose expression
decreased more than that value on the x axis. The
list of genes containing non-conserved and con-
served miR-324-5p binding sites was obtained from
TargetScan [31].
Statistical analysis
Statistical differences were calculated using a one-
or two-way analysis of variance followed byBonferroni
post hoc test for multiple comparisons or Student's t-
test performed for single comparisons. Enrichment
was calculated using Chi-squared test. *p b 0.05,
**p b 0.01, ***p b 0.001, ns = p N 0.05. Statistical
test is indicated within figure legends.Acknowledgements
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